Range
- - -
Vol / Avg.
-/96.9K
Div / Yield
-
52 Wk
9.21 - 28.27
Mkt Cap
377.3M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.56
Shares
36.8M
Outstanding
36.8M
Total Float
19.4M
Sector: Health Care.Industry: Biotechnology
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-09-04
REV
Q1 2021Est.ActualSurprise
EPS-0.620
REV286.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
FHTXFoghorn Therapeutics0%377.3M

Foghorn Therapeutics Frequently Asked Questions

Q

How do I buy Foghorn Therapeutics (FHTX) stock?

A

You can purchase shares of Foghorn Therapeutics (NASDAQ: FHTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Foghorn Therapeutics's (FHTX) competitors?

Q

What is the target price for Foghorn Therapeutics (FHTX) stock?

A

The latest price target for Foghorn Therapeutics (NASDAQ: FHTX) was reported by Morgan Stanley on March 23, 2021. The analyst firm set a price target for 23.00 expecting FHTX to rise to within 12 months (a possible 124.61% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Foghorn Therapeutics (FHTX)?

A

The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $10.24 last updated Wed Jun 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Foghorn Therapeutics (FHTX) pay a dividend?

A

There are no upcoming dividends for Foghorn Therapeutics.

Q

When is Foghorn Therapeutics (NASDAQ:FHTX) reporting earnings?

A
Foghorn Therapeutics’s Q2 earnings are confirmed for after-market on September 4, 2021.
Q

Is Foghorn Therapeutics (FHTX) going to split?

A

There is no upcoming split for Foghorn Therapeutics.

Q

What sector and industry does Foghorn Therapeutics (FHTX) operate in?

A

Foghorn Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.